Mehta A K, Shank R P
R.W. Johnson Pharmaceutical Research Institute, Spring House PA 19477-0776, USA.
Life Sci. 1995;57(24):2215-22. doi: 10.1016/0024-3205(95)02126-4.
Abecarnil, bretazenil, and Ro 19-8022 inhibited the binding of [3H]Ro 15-4513 to diazepamsensitive and -insensitive sites in the rat cerebellum and cerebral cortex, but all three had a much higher affinity for the diazepam-sensitive sites in both tissues. The GABA-shift for bretazenil and Ro 19-8022 was low ( < 2) for all sites studied, consistent with their partial agonistic profile. The GABA-shift for abecarnil was appreciably higher for diazepam-sensitive binding in the cerebellum than in the cerebral cortex (1.97 vs 1.18). Furthermore, the GABA-shift for abecarnil was markedly different for the diazepam-sensitive and -insensitive sites in the cerebellum (1.97 vs 0.71). All three compounds inhibited [3H]Ro 15-4513 binding to the diazepam-sensitive sites with a slope factor > 1, suggestive of positive cooperativity in their binding to GABAA receptors. Abecarnil only partially inhibited diazepam-insensitive binding of [3H]Ro 15-4513 in the cerebellum, indicating that this site can be differentiated into abecarnil-sensitive and -insensitive components.
阿贝卡尼、布雷替齐尼和Ro 19-8022抑制了[3H]Ro 15-4513与大鼠小脑和大脑皮质中地西泮敏感和不敏感位点的结合,但这三种化合物对两种组织中的地西泮敏感位点都具有更高的亲和力。对于所有研究的位点,布雷替齐尼和Ro 19-8022的GABA位移较低(<2),这与其部分激动剂特性一致。阿贝卡尼在小脑中对地西泮敏感结合的GABA位移明显高于大脑皮质(1.97对1.18)。此外,阿贝卡尼在小脑中对地西泮敏感和不敏感位点的GABA位移明显不同(1.97对0.71)。这三种化合物均以斜率因子>1抑制[3H]Ro 15-4513与地西泮敏感位点的结合,提示它们与GABAA受体结合时具有正协同性。阿贝卡尼仅部分抑制了小脑中[3H]Ro 15-4513对地西泮不敏感的结合,表明该位点可分为阿贝卡尼敏感和不敏感成分。